Markus Messerli

752 total citations
17 papers, 506 citations indexed

About

Markus Messerli is a scholar working on Geriatrics and Gerontology, Family Practice and Economics and Econometrics. According to data from OpenAlex, Markus Messerli has authored 17 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 6 papers in Family Practice and 5 papers in Economics and Econometrics. Recurrent topics in Markus Messerli's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Medication Adherence and Compliance (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Markus Messerli is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Medication Adherence and Compliance (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Markus Messerli collaborates with scholars based in Switzerland, Netherlands and Ireland. Markus Messerli's co-authors include Kurt E. Hersberger, Isabelle Arnet, Noortje Vriends, J. W. Foppe van Mil, Mitja Kos, Nina Griese‐Mammen, Nejc Horvat, Saija Leikola, Eva Blozik and Ivo Abraham and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ Open and BMC Health Services Research.

In The Last Decade

Markus Messerli

17 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Messerli Switzerland 11 314 217 129 88 85 17 506
Eline Tommelein Belgium 11 403 1.3× 218 1.0× 222 1.7× 118 1.3× 85 1.0× 32 706
Barbara Hill-Taylor Canada 6 419 1.3× 134 0.6× 219 1.7× 96 1.1× 86 1.0× 9 474
Nina Griese‐Mammen Germany 11 280 0.9× 232 1.1× 85 0.7× 79 0.9× 195 2.3× 14 463
Gülistan Bahat Türkiye 9 433 1.4× 133 0.6× 231 1.8× 69 0.8× 89 1.0× 18 578
Joice Mara Cruciol-Souza Brazil 9 390 1.2× 131 0.6× 84 0.7× 131 1.5× 114 1.3× 12 540
Lene Juel Kjeldsen Denmark 13 412 1.3× 185 0.9× 124 1.0× 121 1.4× 105 1.2× 40 593
Nejc Horvat Slovenia 10 319 1.0× 128 0.6× 106 0.8× 72 0.8× 44 0.5× 15 406
Eva Delgado Silveira Spain 12 453 1.4× 169 0.8× 145 1.1× 104 1.2× 84 1.0× 38 552
Daniel Sevilla‐Sánchez Spain 13 302 1.0× 123 0.6× 136 1.1× 46 0.5× 60 0.7× 35 413
Bo Hovstadius Sweden 12 473 1.5× 192 0.9× 247 1.9× 110 1.3× 153 1.8× 20 710

Countries citing papers authored by Markus Messerli

Since Specialization
Citations

This map shows the geographic impact of Markus Messerli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Messerli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Messerli more than expected).

Fields of papers citing papers by Markus Messerli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Messerli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Messerli. The network helps show where Markus Messerli may publish in the future.

Co-authorship network of co-authors of Markus Messerli

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Messerli. A scholar is included among the top collaborators of Markus Messerli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Messerli. Markus Messerli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hersberger, Kurt E., et al.. (2023). Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot. BMC Infectious Diseases. 23(1). 384–384. 7 indexed citations
2.
Messerli, Markus, et al.. (2020). Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?. SHILAP Revista de lepidopterología. 8(1). 19–19. 7 indexed citations
3.
Albert, Valérie, et al.. (2020). Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies. SHILAP Revista de lepidopterología. 8(2). 54–54. 10 indexed citations
5.
Locher, Cosima, Markus Messerli, Jens Gaab, & Heike Gerger. (2019). Long-Term Effects of Psychological Interventions to Improve Adherence to Antiretroviral Treatment in HIV-Infected Persons: A Systematic Review and Meta-Analysis. AIDS Patient Care and STDs. 33(3). 131–144. 18 indexed citations
6.
Reber, Emilie, Markus Messerli, Zeno Stanga, & Stefan Mühlebach. (2019). Pharmaceutical Aspects of Artificial Nutrition. Journal of Clinical Medicine. 8(11). 2017–2017. 17 indexed citations
7.
Messerli, Markus. (2019). Medikamente via Sonde: eine interprofessionelle Herausforderung. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 1 indexed citations
8.
Messerli, Markus, Noortje Vriends, & Kurt E. Hersberger. (2018). Humanistic outcomes and patient acceptance of the pharmacist-led medication review “Polymedication Check” in primary care in Switzerland: a prospective randomized controlled trial. Patient Preference and Adherence. Volume 12. 1071–1078. 12 indexed citations
9.
Griese‐Mammen, Nina, Kurt E. Hersberger, Markus Messerli, et al.. (2018). PCNE definition of medication review: reaching agreement. International Journal of Clinical Pharmacy. 40(5). 1199–1208. 166 indexed citations
10.
11.
Messerli, Markus, et al.. (2017). Swallowing difficulties with medication intake assessed with a novel self-report questionnaire in patients with systemic sclerosis – a cross-sectional population study. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Sutherland, C. Simone, et al.. (2017). A Cost-Utility Analysis Of Raasi Enabling-Patiromer In Patients With Hyperkalemia. Value in Health. 20(9). A490–A490. 5 indexed citations
13.
Messerli, Markus, Eva Blozik, Noortje Vriends, & Kurt E. Hersberger. (2016). Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial. BMC Health Services Research. 16(1). 145–145. 82 indexed citations
14.
Hersberger, Kurt E. & Markus Messerli. (2016). Development of Clinical Pharmacy in Switzerland: Involvement of Community Pharmacists in Care for Older Patients. Drugs & Aging. 33(3). 205–211. 29 indexed citations
15.
Messerli, Markus, et al.. (2016). Mapping clinical pharmacy practice in Swiss hospitals: a cross-sectional study. European Journal of Hospital Pharmacy. 23(6). 314–319. 15 indexed citations
16.
Arnet, Isabelle, et al.. (2016). Proposal of Standardization to Assess Adherence With Medication Records. Annals of Pharmacotherapy. 50(5). 360–368. 64 indexed citations
17.
Arnet, Isabelle, Ivo Abraham, Markus Messerli, & Kurt E. Hersberger. (2013). A method for calculating adherence to polypharmacy from dispensing data records. International Journal of Clinical Pharmacy. 36(1). 192–201. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026